
Bio Medict is an AI-powered application that objectively measures pain using biometrics to improve clinical outcomes. It continuously monitors pain through patient biometrics, providing essential insights into the duration, type, and intensity of pain. This innovative approach addresses the shortcomings of traditional pain scales, which are often subjective and fail to capture the full context of a patient's experience. By enabling doctors to remotely track pain and adjust treatment plans based on objective data, Bio Medict aims to enhance pain management, reduce opioid dependency, and improve overall patient quality of life. The application is applicable across various medical fields, including surgical recovery, oncology, and orthopedics, making it a versatile tool in pain treatment.

Bio Medict is an AI-powered application that objectively measures pain using biometrics to improve clinical outcomes. It continuously monitors pain through patient biometrics, providing essential insights into the duration, type, and intensity of pain. This innovative approach addresses the shortcomings of traditional pain scales, which are often subjective and fail to capture the full context of a patient's experience. By enabling doctors to remotely track pain and adjust treatment plans based on objective data, Bio Medict aims to enhance pain management, reduce opioid dependency, and improve overall patient quality of life. The application is applicable across various medical fields, including surgical recovery, oncology, and orthopedics, making it a versatile tool in pain treatment.
What they do: AI-powered app that uses continuous biometric data to objectively monitor and measure chronic pain
Clinical focus: Chronic pain across surgical recovery, oncology, neuropathy, orthopedics, and sports medicine
Key signals: Proprietary AI models using heart rate, HRV, sleep, and activity data
Founded: 2024
Headquarters: Boston, Massachusetts
Chronic pain assessment and remote pain monitoring across multiple medical specialties.
2024
Biotechnology
100000
Funding amount and date reported; investor names not confirmed in the provided evidence for the specified domains.